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Abstract
Focal adhesion kinase (FAK) prevents apoptosis in
many cell types. We have reported that tyrosine
residues in FAK are dephosphorylated and FAK is
degraded during mannitol-induced apoptosis in hu-
man neuroblastoma cells. Several studies suggest that
FAK dephosphorylation and degradation are separate
events. The current study defines the relationship
between FAK dephosphorylation and degradation in
neuroblastoma cells using okadaic acid (OA). OA, a
serine phosphatase inhibitor, promotes serine/threo-
nine phosphorylation, which in turn blocks tyrosine
phosphorylation. OA induced focal adhesion loss,
actin cytoskeleton disorganization, and cellular de-
tachment, which corresponded to a loss of FAK Tyr397
phosphorylation. These changes preceded caspase-3
activation, Akt and MAP kinase activity loss, protein
ubiquitination, and cellular apoptosis. Insulin-like
growth factor-I prevented mannitol-induced, but not
OA-induced, substrate detachment and FAK Tyr397
dephosphorylation, and the effects of OA on FAK
Tyr397 phosphorylation were irreversible. The proteo-
lytic degradation of FAK is temporally distinct from its
tyrosine dephosphorylation, occurring when apoptotic
pathways are already initiated and during a general-
ized destruction of signaling proteins. Therefore,
agents resulting in the dephosphorylation of FAK
may be beneficial for therapeutic treatment, irrespec-
tive of FAK protein levels, as this may result in
apoptosis, which cannot be prevented by growth
factor signaling.
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Introduction
Neuroblastoma, a pediatric tumor arising from improper
differentiation of the neural crest, is largely chemoresistant
in children over 12 months of age [1]. Long-term survival
rates are inadequate, and over 40% of children die of
metastatic disease [2], with primary metastatic sites includ-
ing the bone, liver, and lungs [3–5]. Many chemotherapeu-
tic agents induce a caspase-8–dependent apoptotic death in
tumor cells [6]. However, neuroblastoma tumors often have
defects in caspase-8–mediated apoptotic pathways, or over-
express antiapoptotic proteins of the Bcl-2 family, which may
explain their chemoresistant behavior [7]. Therefore, in our
laboratory, we have focused on alternative ways to induce
apoptosis in human neuroblastoma cells, primarily to under-
stand which biochemical pathways to target during neuroblas-
toma treatment.
We have shown that mannitol, which causes hyperosmotic
stress in cells, induces apoptosis in both neuroblastic (N-type)
and substrate-adherent (S-type) cells derived from heteroge-
neous neuroblastoma tumors [8–10]. Mannitol induces cas-
pase-3 activation within 3 to 9 hours, DNA fragmentation within
12 hours, and membrane alterations by 24 hours after treat-
ment [8–10]. We have also shown that mannitol treatment
leads to morphological changes by 4 hours, with disruptions in
actin cytoskeleton and degradation of both the survival protein
Akt and focal adhesion kinase (FAK) [11]. This coincides with a
loss of focal adhesion sites, cell detachment, and eventual cell
death [11]. FAK activation appears to be essential in preventing
anoikis [12], a form of apoptosis that occurs when anchorage-
dependent cells detach from their substrate [13]. Therefore,
these changes have led us to postulate that mannitol induces
an anoikis-like death through its effects on FAK.
FAK is a cytoplasmic tyrosine kinase central in many critical
cellular pathways [12,14,15]. FAK is tyrosine-phosphorylated
upon integrin ligand binding [16] or downstream of ligand
binding by growth factor receptors [17,18]. FAK is located at
focal adhesion sites where it forms complexes with down-
stream signaling molecules, such as phosphatidylinositol-
3-kinase, Grb2, Shc, Src, and paxillin [16]. FAK activation at
focal adhesion sites leads to cytoskeletal reorganization, cel-
lular adhesion, and survival.
Address all correspondence to: Eva L. Feldman, MD, PhD, Department of Neurology,
University of Michigan, 4414 Kresge III, 200 Zina Pitcher Place, Ann Arbor, MI 48109-0588,
USA. E-mail: efeldman@umich.edu
1This work was supported by the National Institutes of Health (NS38849 and NS36778), the
Juvenile Diabetes Research Foundation Center for the Study of Complications in Diabetes,
and the Program for Understanding Neurological Diseases (PFUND).
Received 18 July 2003; Revised 29 August 2003; Accepted 16 September 2003.
Copyright D 2003 Neoplasia Press, Inc. All rights reserved 1522-8002/03/$25.00
Neoplasia . Vol. 5, No. 5, September/October 2003, pp. 405–416 405
www.neoplasia.com
RESEARCH ARTICLE
Microinjection of an anti-FAK antibody or FAK antisense
oligonucleotides, preventing FAK activation, induces apo-
ptosis [15,19]. Conversely, overexpression of FAK prevents
apoptosis caused by cellular detachment [14], ultraviolet
irradiation [20], hydrogen peroxide, or etoposide [21].
Results from previous studies suggest that FAK dephos-
phorylation and degradation are both coupled to anoikis [22].
However, other studies suggest that FAK dephosphorylation
and degradation are not directly connected [23]. Therefore,
to help clarify the role of FAK in neuroblastoma cell death, we
examined its modification during anoikis induced by okadaic
acid (OA), an inhibitor of the serine/threonine protein phos-
phatases 1 (PP1) and 2A (PP2A). OA induces apoptosis in a
wide variety of cell types, including mouse keratinocytes [24],
renal epithelial tumor cells [25], oral squamous carcinoma
cells [26,27], lung fibroblasts [28], and cultured neuronal
cells [29,30]. OA-induced apoptosis occurs through several
mechanisms, including phosphorylation of p53 [31] and
upregulation of the Fas receptor [26]. OA also results in
caspase-2, caspase-3, caspase-7, and caspase-9 in multiple
cell types, with no activation of caspase-8 [32]. However, the
major observation in OA-treated cells is the disruption of the
actin cytoskeleton [33,34]. Therefore, in this study, we
examined the effect of OA on FAK phosphorylation, FAK
degradation, and apoptosis to determine the role of FAK in
neuroblastoma cell apoptosis.
In the current study, we show that OA induces a loss of
focal adhesions, disorganization of the actin cytoskeleton,
cellular detachment, and cellular rounding. These events
correspond with a loss of FAK phosphorylation on Tyr397,
serine phosphorylation and degradation of paxillin, activation
of caspase-3, loss of Akt and MAP kinase, protein ubiquiti-
nation, and detection of apoptosis by flow cytometry. Insulin-
like growth factor-I (IGF-I) prevents mannitol-induced, but
not OA-induced, substrate detachment and FAK Tyr397
dephosphorylation, and the effects of OA on FAK Tyr397
phosphorylation were irreversible. These results suggest
that OA causes an irreversible change in paxillin or another
upstream signaling molecule that disrupts focal adhesion
complexes and prevents FAK activation and autophosphoryl-
ation. Finally, the proteolytic degradation of FAK is tempo-
rally distinct from its tyrosine dephosphorylation, occurring
when apoptotic pathways are already initiated and during a
generalized destruction of signaling proteins. These results
suggest that FAK dephosphorylation and degradation are
separable processes. Therefore, agents resulting in the
dephosphorylation of FAK may be beneficial for therapeutic
treatment, irrespective of FAK protein levels, as this may
result in apoptosis, which cannot be prevented by growth
factor signaling.
Materials and Methods
Materials
Antibodies against phosphorylated FAK (pFAK, pY397,
and pS722) were purchased from Biosource International
(Camarillo, CA). Anti-FAK monoclonal and PY20 antiphos-
photyrosine antibodies were purchased from Transduction
Laboratories (Lexington, KY). Antibodies against phosphor-
ylated and unphosphorylated Akt and mitogen-activated
protein kinase (MAPK) were from Cell Signaling Technology
(Beverly, MA). Anticaspase-3 antibody was from BD Phar-
Mingen (San Diego, CA). Antibodies against actin, ubiquitin,
and FAK (polyclonal); secondary antibodies for Western
immunoblotting; and protein A/G agarose beads were from
Santa Cruz Biotechnology (Santa Cruz, CA). Texas Red–
conjugated phalloidin, biotin-labeled secondary antibodies,
and fluorescein isothiocyanate (FITC)– labeled avidin were
from Vector Laboratories (Burlingame, CA). OA and other
inhibitors were purchased from Calbiochem (La Jolla, CA).
Recombinant human IGF-I was kindly provided by Cephalon,
Inc. (Westchester, PA).
Cell Culture
SH-EP human neuroblastoma cells were maintained in
DMEM containing 10% calf serum. SH-EP cells transfected
with vector (pSFFV) or IGF-IR cDNA [35] were maintained in
DMEM containing 10% calf serum and 0.25 mg/ml G418.
The cells were serum-starved for 4 hours before each
experiment.
Immunoblotting, Immunoprecipitation, and
Immunocytochemisty
Immunoblotting and immunoprecipitation were performed
as previously described [36]. All experiments were repeated
at least three times and typical representative results are
presented in the figures. Immunocytochemistry was per-
formed as described previously [37] using an anti-FAK
monoclonal antibody and Texas Red phalloidin.
Flow Cytometry
The percentage of apoptotic cells was measured as the
percentage of sub-G0 DNA using flow cytometry as de-
scribed previously [10]. All results are expressed as the
mean percentage of apoptotic cells of at least three experi-
ments ± the standard error of the mean (SEM).
Results
OA Induces Cell Detachment, Actin Stress Fiber Disruption,
and Loss of Focal Adhesion Sites in SH-EP Human
Neuroblastoma Cells
We recently reported that hyperosmotic media induce
apoptosis in neuroblastoma cells [9,38–40]. One of the
earliest events observable with mannitol treatment is disrup-
tion of the actin cytoskeleton [11]. The phosphatase inhib-
itors OA and cytostatin, which inhibit PP1 and PP2A, cause a
similar disruption of the actin cytoskeleton [33,34] and induce
apoptosis [41–43]. Therefore, we were interested in whether
comparable biochemical pathways were involved in manni-
tol- and OA-induced morphological changes and apoptosis.
For these studies, we utilized SH-EP human neuroblastoma
cells, which we have previously used to characterize man-
nitol-induced apoptosis [10,11]. In initial studies, SH-EP cells
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were serum-starved for 4 hours and then treated for 4 hours
with or without 250 nM OA. The control untreated cells were
elongated and well spread, and most of the cells were
attached to the substrate. However, upon OA treatment,
SH-EP cells rounded up and detached from the substrate
(Figure 1A). Control cells contained well-organized actin
stress fibers, as visualized through staining with Texas Red
phalloidin (Figure 1B, left panel), whereas the actin cyto-
skeleton was disrupted in OA-treated cells. Immunostaining
for the focal adhesion protein FAK revealed a typical punc-
tate pattern at the sites of focal adhesion in control cells.
However, this punctate pattern was lost in OA-treated
cells, suggesting a loss of focal adhesion formation. These
results indicate that initial cellular events occurring after OA
treatment are a loss of actin stress fibers and focal
adhesions concomitant with rounding up and detachment
Figure 1. OA causes detachment of SH-EP cells. (A) Phase contrast microscopy of SH-EP neuroblastoma cells serum-starved for 4 hours and treated for 4 hours
with or without 250 nM OA. (B) The cells were treated as in (A), fixed, and stained with Texas red phalloidin and anti-FAK antibody.
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of cells, similar to our observations in mannitol-treated
cells [11].
OA Induces Concentration- and Time-Dependent
Dephosphorylation of FAK
Our initial results suggested that FAK is modified by OA
treatment. Tyr397 phosphorylation indicates FAK activation,
as FAK phosphorylates itself on Tyr397 [44]. Therefore, we
utilized an anti–phospho-Tyr397–specific antibody to deter-
mine the effect of OA on FAK tyrosine phosphorylation and
activity. OA treatment caused a concentration- and time-
dependent decrease in the phosphorylation of FAK at Tyr397
(Figure 2A). FAK tyrosine phosphorylation decreased at OA
concentrations between 100 and 250 nM, and Tyr397 phos-
phorylation was completely lost at 500 nM. FAK Tyr397
phosphorylation began to decrease after 2 to 3 hours of
OA treatment, and this site was completely dephosphory-
lated after 4 hours (Figure 2A). In contrast, little change
occurred in FAK Ser722 phosphorylation (Figure 2B), and the
levels of FAK protein remained constant during OA treatment
(Figure 2C).
We next examined the effect of OA on paxillin, a focal
adhesion protein that associates with and targets FAK to
focal adhesions [45]. OA caused a time- and concentra-
tion-dependent loss of paxillin tyrosine phosphorylation
(Figure 2D). In contrast to FAK, OA also appeared to
induce the degradation of paxillin, or at least a reduction
in its levels (Figure 2E). The decrease in paxillin expres-
sion occurred in parallel with reduced electrophoretic mo-
bility, suggesting that OA enhanced the phosphorylation of
paxillin on serine or threonine. Finally, OA treatment did
not cause a change in the levels of Akt, Erk1/2, or actin
(Figure 2F–H), demonstrating that OA does not cause a
generalized degradation of cellular proteins.
FAK Tyr397 dephosphorylation coincided with morpholog-
ical changes induced by OA. Specifically, the cells began to
round up and lose their attachment within 3 hours of OA
treatment (Figure 3), the same time point at which FAK
phosphorylation begins to decrease. Furthermore, most of
the cells were detached after 4 hours, when the Tyr397 of
FAK is completely dephosphorylated. These results strongly
suggest that FAK tyrosine phosphorylation is connected to
morphological and cytoskeletal changes caused by OA.
Influences of IGF-IR Signaling on OA-Induced FAK
Dephosphorylation and Morphological Changes
The activation of IGF-IR is important for transformation
and tumor progression in several tumor types [46,47]. IGF-IR
activation and downstream signaling promote both cell pro-
liferation [48–53] and cell survival [54,55] and rescue cells
from apoptosis caused by a wide variety of agents [56]. In
fact, we have shown that IGF-I treatment or IGF-IR over-
expression prevents mannitol-induced apoptosis in SH-EP
cells [8–11,39]. Furthermore, IGF-IR activation prevents
mannitol-induced FAK dephosphorylation and degradation
[11]. IGF-I treatment [42] or IGF-IR overexpression [43] also
prevents OA-induced apoptosis in other cell lines. Therefore,
we examined the effect of IGF-IR overexpression and acti-
vation on OA-induced changes in SH-EP cells.
When serum-starved control SH-EP cells transfected
with empty pSFFV vector (SHEP/pSFFV cells) were trea-
ted with IGF-I, there was a slight increase in both Tyr397
(Figure 4A) and total FAK tyrosine phosphorylation
(Figure 4C). In agreement with our previous report [11],
mannitol induced a complete degradation of FAK, as well
as a loss of both Tyr397 and total tyrosine phosphorylation.
Akt is also degraded during mannitol treatment. These
effects of mannitol on FAK and Akt were prevented by
IGF-I treatment. Like mannitol, OA induced both Tyr397
and total tyrosine dephosphorylation. However, in contrast
to mannitol, OA did not cause the degradation of FAK or
Akt. IGF-I treatment, although effective against mannitol-
induced FAK dephosphorylation, did not prevent OA-
induced FAK dephosphorylation. Neither mannitol nor OA
caused a change in the level of Erk 1/2. As previously
reported [11], IGF-IR overexpression reduced the manni-
tol-stimulated dephosphorylation of FAK on Tyr397 (Figure
4B) but was unable to prevent OA-induced FAK Tyr397
dephosphorylation, whether or not IGF-I was present. In
addition, IGF-IR overexpression reduced mannitol-induced
FAK and Akt degradation. Collectively, these results show
that OA-induced FAK tyrosine dephosphorylation cannot
be rescued by IGF-IR activation. This contrasts directly
with the effects of mannitol, which can be reversed by IGF-IR
activation.
Figure 2. OA induces time- and concentration-dependent dephosphorylation
of FAK. SH-EP cells were serum-starved for 4 hours and treated with
increasing concentrations of OA for 4 hours (left panel), or with 250 nM OA for
the indicated times (right panel). Equal amounts of protein from whole cell
lysates were separated by SDS-PAGE, transferred to nitrocellulose, and
analyzed by immunoblotting with the indicated antibodies (A–H).
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Given that IGF-I was able to rescue mannitol-induced, but
not OA-induced, FAK tyrosine dephosphorylation, we sus-
pected that IGF-I might also prevent the morphological
changes caused by mannitol but not OA. Mannitol induced
cell detachment and morphological changes associated with
apoptosis, including membrane blebbing, loss of contacts
with neighboring cells, rounding up, and detachment from
the substrate (Figure 5), similar to our previous report [11].
As expected, these changes were prevented by IGF-I treat-
ment. Like mannitol, OA induced the rounding up and
detachment of cells from the substrate. However, unlike cells
exposed to mannitol, cells treated with OA did not display the
extensive membrane blebbing typical of apoptosis [11].
Moreover, IGF-I was unable to prevent OA-induced rounding
and loss of substrate attachment.
Influences of Integrin Signaling on OA-Induced FAK
Dephosphorylation
FAK is activated downstream of both growth factor recep-
tors [17,18] and integrins [16]. Therefore, because growth
factor receptor activation failed to prevent OA-induced FAK
dephosphorylation, we next examined the effect of integrin
ligand binding on FAK phosphorylation. SH-EP cells grown
on fibronectin display slightly elevated FAK Tyr397 compared
with cells grown on plastic (Figure 6).
Treatment of SH-EP cells grown on fibronectin with
250 nM OA for 4 hours caused a complete loss of Tyr397
phosphorylation without affecting the protein levels of FAK or
actin. These results demonstrate that fibronectin activation
of integrins cannot prevent OA-induced FAK tyrosine de-
phosphorylation, and that the effects of OA are not limited to
cells growing on a plastic surface. Therefore, unlike mannitol
treatment, neither growth receptor activation nor integrin
ligand binding prevents OA-induced FAK dephosphorylation.
Reversibility of OA-Induced FAK Dephosphorylation
To determine whether the effects of OA on FAK phos-
phorylation are reversible, we treated cells with 250 nM OA
for 1 to 4 hours, then changed the medium to fresh DMEM.
FAK dephosphorylation on Tyr397 cannot be reversed after 2
hours of OA treatment (Figure 7). We also examined the
phosphorylation of Akt, which is thought to be dephosphory-
lated by PP2B [57]. As expected, Akt phosphorylation was
enhanced by OA, and switching the medium to fresh DMEM
returned Akt phosphorylation to basal levels. IGF-I stimulat-
ed Akt phosphorylation in the fresh medium, even after 4
Figure 3. OA induces time-dependent detachment of SH-EP cells. Serum-starved SH-EP cells were incubated with or without 250 nM OA. Phase contrast images
were taken at the indicated times.
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hours of OA treatment, despite the fact that the cells are
completely rounded up at this time point. These results show
that the effects of OA on FAK are irreversible, suggesting
that OA causes a permanent covalent modification of FAK or
another upstream signaling molecule. Irreversibility is not a
general feature of OA treatment, as its effects on Akt are
readily reversible.
Short-Term Effects of OA on Apoptotic Pathways in SH-EP
Cells
Our previous studies showed that caspases are actively
involved in mannitol-induced or glucose-induced apoptosis
Figure 5. Effect of IGF-I on OA-induced morphological changes and cell
detachment. Serum-starved vector-transfected SH-EP cells were treated for
4 hours with 300 mM mannitol or 250 nM OA in the presence or absence of
10 nM IGF-I. Representative phase contrast images are shown.
Figure 4. Effect of IGF-I on OA-induced FAK dephosphorylation. Vector-
transfected (A and C) or IGF-IR – transfected (B) SH-EP cells were treated
for 4 hours with or without 300 mM mannitol (Man) or 250 nM OA in the
presence or absence of 10 nM IGF-I. Whole cell lysates were analyzed by
immunoblotting with indicated antibodies (A and B). (C) Whole cell lysates
were immunoprecipitated with an anti-FAK polyclonal antibody and then
analyzed by immunoblotting with an antiphosphotyrosine (pTyr) antibody
(upper panel). The immunoblot was stripped and reblotted with an anti-
FAK monoclonal antibody (lower panel). IB = immunoblot; IP =
immunoprecipitation.
Figure 6. Effect of integrin activation on OA-induced FAK dephosphorylation.
SH-EP cells were grown on plastic (Plas) or fibronectin (FN) for 3 days. After
serum starvation, the cells were treated for 4 hours with 250 nM OA, and
whole cell lysates were analyzed by immunoblotting with anti –phospho-FAK
(pY397), anti-FAK, or antiactin antibodies.
Figure 7. Reversibility of OA-induced FAK dephosphorylation. Serum-
starved SH-EP cells were treated with OA for 1 to 4 hours. Cell lysates
were collected (a) immediately after OA treatment, or cells were washed and
incubated for 3 hours in (b) DMEM or (c) DMEM+10 nM IGF-I. Equal amounts
of whole cell lysates were separated by SDS-PAGE, transferred to
nitrocellulose, and analyzed by immunoblotting with anti –phospho-FAK
(pY397), anti –phospho-Akt, or antiactin antibodies.
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[10,58,59]. Furthermore, caspase-3 cleavage has been
linked to OA-induced apoptosis in other cell types
[25,28,60]. Therefore, we examined the effect of OA on
caspase-3 cleavage in SH-EP cells (Figure 8A). We also
analyzed the effects of OA on the proteasome/ubiquitin
pathway (Figure 8B), which participates in apoptosis and
Figure 8. Effect of OA on apoptotic pathways. SH-EP cells were treated for 4 hours with or without 300 mM mannitol or 250 nM OA in the presence or absence of
10 nM IGF-I. Whole cell lysates were analyzed by immunoblotting with (A) anti – caspase-3 or (B) antiubiquitin antibodies. Intact (arrowhead) and cleaved (arrow)
forms of caspase-3 are indicated. (C) SH-EP cells were treated as above, and the number of apoptotic cells was measured by flow cytometry.
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the breakdown of cellular proteins [61,62]. After 4 hours of
OA treatment, when FAK is fully dephosphorylated and the
cells have completed rounding up and detachment, we did
not observe caspase-3 cleavage, accumulation of ubiquiti-
nated proteins, or apoptosis (Figure 8). In contrast, a 4-hour
treatment with mannitol caused caspase-3 cleavage, protein
ubiquitination, and subsequent apoptosis—effects that were
blocked by IGF-I (Figure 8) [11].
Long-Term Effects of OA on Apoptotic Pathways in SH-EP
Cells
Cells denied anchorage will undergo a form of apoptosis
called anoikis [13]. Surprisingly, although OA acid treatment
induces cellular detachment, it does not stimulate caspase-3
cleavage, ubiquitination, or accumulation of apoptotic cells.
We therefore suspected that the induction of apoptosis was
delayed beyond the 4-hour time point. Indeed, when SH-EP
cells were treated with 250 nM OA for 8 hours (4 hours after
they lost substrate adhesion), they began to show biochem-
ical changes characteristic of apoptosis. First, treatment with
OA for 8 hours induced the cleavage of FAK (Figure 9A).
This cleavage of FAK was complete after 24 hours of OA
treatment. We previously reported a similar breakdown of
FAK and Akt during mannitol-induced apoptosis in SH-EP
cells [11]. In contrast to the degradation of FAK, dephos-
phorylation of FAK Tyr397 is easily observed after 4 hours of
Figure 9. Time course of OA-induced apoptosis. SH-EP cells were treated for 4 to 24 hours with or without 250 nM OA. (A–C) Whole cell lysates were analyzed by
immunoblotting with indicated antibodies. Intact (arrowhead) and cleaved (arrow) forms of caspase-3 are indicated. (D) SH-EP cells were treated as above and the
number of apoptotic cells was measured by flow cytometry.
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OA treatment, although, like FAK degradation, it continues
with extended OA treatment. Little change in FAK Ser722
phosphorylation is observed at the 4-hour time point; how-
ever, it also decreases at later time points. These results
suggest that FAK dephosphorylation progresses at later
(8–24 hours) time points, although it is difficult to determine
whether the loss of anti-pTyr397 and anti-pSer722 immuno-
blotting is truly due to continued dephosphorylation, or simply
a loss of the antigenic epitope due to proteolytic cleavage.
Finally, long-term OA treatment also caused substantial
degradation of Akt and Erk 1/2, but not actin, suggesting
that extended treatment with OA induces a general degra-
dation of signaling proteins in SH-EP cells.
Similar to FAK cleavage, caspase-3 cleavage, although
not observable after 4 hours of OA treatment, was readily
observed within 8 hours (Figure 9B). Likewise, protein ubiq-
uitination is not apparent after 4 hours of OA treatment, but is
easily detected after 8 hours (Figure 9C). These results
confirm that apoptotic pathways are triggered only after
extended treatment with OA. In agreement with these find-
ings, flow cytometry revealed that OA causes substantial
apoptosis only after 8 hours (Figure 9D).
Discussion
Anoikis is an apoptotic process that occurs in cells denied
cell–matrix or cell–cell attachment [63]. Although many
characteristics of apoptosis are recapitulated in anoikis, the
caspases, which are critical for executing the apoptotic
program, are activated much later in anoikis [64]. Integrin
activation of FAK appears particularly crucial for preventing
anoikis [65]. However, once anoikis has been initiated, other
signaling pathways may protect cells from death, including
Akt activation [66], IGF-I treatment [67], and insulin receptor
overexpression [68]. We have previously shown that expo-
sure of neuroblastoma cells to mannitol causes cell detach-
ment, actin cytoskeleton alterations, FAK dephosphorylation
and degradation, and apoptosis, suggesting an anoikis-like
death [11]. In the current study, we investigated the events
following OA treatment, a known apoptosis inducer, to
determine the role of cellular detachment and FAK dephos-
phorylation in neuroblastoma cell death.
To begin, we examined the effects of OA on the morphol-
ogy of SH-EP neuroblastoma cells. The initial effect of OA is
rounding up of cells and loss of substrate adhesion. These
effects are associated with disorganization of the actin
cytoskeleton, loss of focal adhesions, tyrosine dephosphoryl-
ation of FAK, and degradation of paxillin. At later times, OA
induces apoptosis, which is associated with cleavage of FAK,
caspase-3, and other signaling proteins, as well as the
accumulation of ubiquitinated protein. Thus, tyrosine dephos-
phorylation and proteolysis of FAK are temporally distinct
events associated with different effects of OA.
The morphological effects of OA treatment in SH-EP
cells are similar to the effects of OA in other cell types
[25,33,34,69]. However, unlike other reports [25,33,69], we
did not observe extensive OA-induced membrane blebbing,
a characteristic of cells undergoing apoptosis, which is
readily detected in mannitol-treated SH-EP cells [11]. Fail-
ure to observe OA-induced membrane blebbing is likely
due to a delay in the induction of apoptosis until after the
4-hour time point at which we analyzed cell morphology. In
fact, caspase-3 cleavage, protein ubiquitination, and the
accumulation of apoptotic cells were apparent only after
8 hours of treatment with OA. Our results are supported by
studies of OA-induced apoptosis in other cell types. In
ERC-18 renal epithelial cells, OA induces cell detachment
within 2 hours, caspase cleavage within 6 hours, and
membrane blebbing within 6 to 10 hours [25]. This time
course is very similar to our results. In this report, they
divided the apoptotic process into early, intermediate, and
late events, and suggested that different apoptotic and
necrotic pathways are involved in each process. Similarly,
human lung fibroblasts do not show caspase-3 activation,
DNA fragmentation, or the translocation of phosphatidyl-
serine to the outer plasma membrane leaflet until 12 hours
after OA treatment [28]. Finally, OA leads to apoptosis in
human oral squamous carcinoma cells after 24 hours [26].
These results, along with our findings, suggest that the
induction of apoptosis by OA is indirect, occurring subse-
quent to a loss of focal adhesions and substrate attach-
ment. This is consistent with an anoikis-like death, in which
contact-dependent cells undergo apoptosis after loss of
substrate attachment [12]. However, it is still possible that
other apoptotic signals that we did not test, including p53
activation [31] or expression of Fas ligand and its receptor
[26], are also involved in OA-induced apoptosis in our cells.
The biochemical changes in FAK support our hypothesis
that OA-induced apoptosis occurs subsequent to substrate
detachment similar to anoikis. OA treatment caused a rapid
dephosphorylation of FAK on tyrosine at times (3–4 hours
after OA addition) when focal adhesions and the actin
cytoskeleton are disrupted. We also observed the degrada-
tion, tyrosine dephosphorylation, and apparent serine/threo-
nine phosphorylation of paxillin at these early time points.
Such a connection between cell detachment, cytoskeletal
disorganization, and tyrosine dephosphorylation of FAK and
paxillin is in agreement with our previous findings and many
other reports [22,70]. Integrin stimulation prevents apoptosis
in numerous cell types [63], potentially through increased
attachment of cells to their substrate. In fact, we have
previously shown that b1 integrin prevents mannitol-induced
apoptosis in SH-EP neuroblastoma cells [71]. However,
adhesion of SH-EP cells to fibronectin, the primary extracel-
lular matrix substrate for b1 integrin, did not prevent OA-
induced dephosphorylation of FAK Tyr397. Therefore, neither
IGF-IR expression and activation, nor integrin stimulation is
effective at preventing OA-induced apoptosis.
FAK, Akt, and MAP kinase are degraded at later time
points (8–24 h after OA addition) when caspase-3 is
cleaved and activated, protein ubiquitination is increased,
and apoptosis is readily observed. FAK and Akt cleavage
may be carried out directly by activated caspase-3
[22,72,73]. Levkau et al. [73] noted that cleavage of FAK
appears to precede and contribute to cellular detachment
during apoptosis. Similarly, caspase-dependent cleavage of
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focal adhesion proteins leads to cellular detachment during
neuronal apoptosis [74]. However, in other cells, cellular
detachment and loss of focal adhesions are not due to
caspase cleavage of FAK, but rather, caspase-mediated
cleavage of FAK occurs after the loss of focal adhesions
[22]. Similarly, we observe FAK degradation only when
apoptosis is already occurring (8–24 h after OA addition),
not during the loss of focal adhesion and cell–substrate
attachment (3–4 h after OA addition).
OA-induced dephosphorylation FAK Tyr397 was irrevers-
ible, and occurred prior to the observed proteolytic cleavage
of FAK. This suggests that OA causes some other perma-
nent change in FAK or another upstream signaling molecule.
One likely candidate is the degradation of paxillin observed in
parallel with FAK Tyr397 dephosphorylation. Indeed, paxillin
is thought to target FAK to focal adhesions [45], and its
destruction could account for the loss of FAK activation and
focal adhesion function. A similar degradation of paxillin
preceding apoptosis has been observed in neuronoma
476-16 cells [75].
Phosphorylation of FAK at Tyr397 is thought to suppress
apoptosis by binding and activating phosphatidylinositol-3-
kinase, which, in turn, stimulates the antiapoptotic activity of
Akt [14,21,76,77]. Therefore, the OA-induced tyrosine de-
phosphorylation of FAK Tyr397 may cause apoptosis by
reducing the activity of phosphatidylinositol-3-kinase. This
is exacerbated by the proteolytic degradation of FAK and Akt
that occurs after apoptotic pathways are initiated.
Like integrin activation, IGF-IR activation leads to down-
stream activation of the phosphatidylinositol-3-kinase/Akt
pathway and provides a signal for cellular survival [40].
Indeed, in our previous [11] and current studies, we showed
that IGF-I treatment prevents mannitol-induced apoptosis,
FAK cleavage and dephosphorylation, caspase-3 activation,
and protein ubiquitination. However, IGF-I was unable to
prevent the events induced by OA. This contrasts with the
ability of IGF-I to prevent OA-induced apoptosis in mouse
embryo fibroblasts [43], or in rat cerebellar neurons [42]. One
possible explanation for this difference may be the concen-
trations of OA used. Specifically, the studies in mouse
embryo fibroblasts and rat cerebellar neurons utilized 5 to
25 nM OA, whereas we used 50 to 500 nM OA. For this
reason, we examined the effect of 25 nM OA. Although it
takes more than 48 hours for 25 nM OA to cause morpho-
logical changes in SH-EP cells, IGF-I is ineffective at pre-
venting the effects of this concentration of OA (data not
shown). Therefore, it is more likely that the differences are
due to cell-specific sensitivity to OA responses to IGF-I or
focal adhesion components. Another possibility is that OA
targets the IGF-IR, interfering with its tyrosine kinase activity,
as occurs with ethanol treatment in SH-SY5Y neuroblastoma
cells [78,79].
OA may cause changes in FAK phosphorylation and
function by blocking PP1, PP2A, or both phosphatases.
FAK associates with PP1 [80], and the phosphorylation of
FAK on serine disrupts its association with other focal
adhesion proteins [81,82]. However, we did not observe an
increase in the phosphorylation of FAK on Ser722, nor did we
observe a reduction in its mobility on sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). This sug-
gests that OA does not enhance the phosphorylation of FAK
on serine or threonine. A second possibility is that OA
stimulates FAK tyrosine dephosphorylation via increased
serine phosphorylation of the tyrosine phosphatase SHP2
(also known as PTP1D or Syp) [83,84]. As mentioned
previously, tyrosine dephosphorylation of FAK can disrupt
signaling via the phosphatidylinositol-3-kinase/Akt survival
pathway. Although this may contribute to FAK dephosphoryl-
ation, this does not explain the irreversibility of OA-induced
FAK tyrosine dephosphorylation.
A more plausible mechanism explanation for the effects of
OA involves changes in paxillin. OA inhibits PP2A, which is
known to cause the hyperphosphorylation of paxillin on
serine [81]. In fact, we found that OA reduces the mobility
ofpaxillin onSDS-PAGE,consistentwith itshyperphosphoryl-
ation on serine. Serine phosphorylation of paxillin, in turn,
can disrupt the formation of FAK/Src/paxillin complexes,
thereby preventing FAK activation and signaling [81]. Inter-
estingly, we found that the apparent serine phosphorylation
of paxillin also coincides with its degradation. We therefore
speculate that OA-induced serine phosphorylation targets
paxillin for destruction, in a manner similar to NFnB [85]. The
degradation of paxillin, in turn, would prevent FAK from
associating with focal adhesions, blocking FAK activation
and autophosphorylation. This simple model could explain
why the effects of OA on FAK tyrosine phosphorylation are
irreversible and insensitive to IGF-IR activation.
In summary, we have shown that OA causes both deg-
radation and dephosphorylation of FAK on Tyr397. Dephos-
phorylation of FAK Tyr397 coincides with a loss of focal
adhesions, disorganization of the actin cytoskeleton, degra-
dation of paxillin, cell rounding, and detachment from the
substrate. The degradation of FAK, however, follows the loss
of cell–substrate attachment and occurs during active apo-
ptosis and a general breakdown of signaling molecules
including Akt and MAP kinase. The effects of OA on FAK
Tyr397 phosphorylation cannot be prevented by IGF-I and are
irreversible. Therefore, it appears that OA causes a perma-
nent change in an upstream signaling molecule, perhaps
degradation of paxillin, which is responsible for the loss in
FAK activation and tyrosine phosphorylation. Finally, these
studies suggest that OA causes apoptosis primarily by
disrupting cell adhesion.
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